Clinical Scorecard: The Effectiveness and Safety of Ring-Augmented Roux-en-Y Gastric Bypass with MiniMizer Ring in Patients with a BMI Exceeding 50 kg/m2
At a Glance
Category
Detail
Condition
Severe obesity with BMI ≥ 50 kg/m2
Key Mechanisms
Ring augmentation of Roux-en-Y gastric bypass (raRYGB) using a MiniMizer silicone ring to enhance long-term weight loss and maintenance
Bariatric surgery centers with experienced surgeons
Key Highlights
Mean total weight loss (%TWL) after raRYGB with MiniMizer ring was 16% at 3 months, 25% at 6 months, 32.1% at 1 year, and 35% at 2 years post-op.
Significant reductions in obesity-related comorbidities including diabetes mellitus, hypertension, and obstructive sleep apnea syndrome were observed up to 2 years post-surgery.
The MiniMizer ring was placed 2–3 cm below the gastro-esophageal junction and fixed with non-absorbable sutures; ring sizes varied by sex with most males receiving 7.5 cm and females 7.0 cm circumference.
Guideline-Based Recommendations
Diagnosis
Screen patients for eligibility for bariatric surgery according to IFSO criteria prior to raRYGB.
Management
Perform laparoscopic ring-augmented RYGB with a 6–8 cm gastric pouch, 60 cm biliopancreatic limb, and 120 cm alimentary limb.
Place MiniMizer silicone ring around gastric pouch 2–3 cm below gastro-esophageal junction and >2 cm above gastro-jejunal anastomosis.
Advise preoperative low-calorie diet for 4–6 weeks to optimize surgical outcomes.
Monitoring & Follow-up
Assess total weight loss (%TWL) and excess weight loss (%EWL) at 3, 6, 12, and 24 months postoperatively.
Monitor for early (<30 days) and late (>30 days) postoperative complications using Clavien Dindo classification, focusing on complications with score ≥ 3a.
Evaluate improvement in obesity-related comorbidities (diabetes, hypertension, OSAS, dyslipidemia) according to ASMBS criteria.
Risks
Perioperative complications may be increased in patients with BMI ≥ 50 kg/m2; ring-related complications should be specifically monitored.
Potential risks include surgical complications related to ring placement and anastomosis.
Patient & Prescribing Data
171 adult patients with BMI ≥ 50 kg/m2 undergoing primary laparoscopic raRYGB with MiniMizer ring
Significant weight loss and comorbidity improvement achieved up to 2 years post-surgery; ring size selection tailored by sex; preoperative weight loss recommended.
Clinical Best Practices
Use standardized surgical technique with calibrated gastric pouch and limb lengths for raRYGB.
Fix MiniMizer ring securely with non-absorbable sutures to prevent migration or complications.
Implement routine closure of Petersen’s space and mesenteric defects to reduce internal hernia risk.
Conduct thorough preoperative screening and optimize patient condition with dietary interventions.
Perform regular postoperative follow-up to monitor weight loss trajectory and comorbidity resolution.
